MD SB342 | 2019 | Regular Session

Status

Spectrum: Committee Bill
Status: Introduced on January 30 2019 - 25% progression, died in committee
Action: 2019-02-01 - Hearing 2/14 at 1:00 p.m.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Requiring the Prescription Drug Monitoring Program to provide prescription monitoring data to authorized users, rather than the authorized administrator, of another state's prescription drug monitoring program; repealing the termination date of the Program; repealing the requirement that the Department of Legislative Services conduct a certain evaluation of the Program under the Maryland Program Evaluation Act; etc.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Prescription Drug Monitoring Program - Program Evaluation

Sponsors


History

DateChamberAction
2019-02-01SenateHearing 2/14 at 1:00 p.m.
2019-01-30SenateFirst Reading Finance

Subjects


Maryland State Sources


Bill Comments

feedback